Table 1: Demographics and clinical traits of the patients with hypertension treated in rural polyclinic settings versus BP control.

Variables Controlled group (n=93) (51%) Uncontrolled group (n=89) (49%) p-values
Female (%), М (95% CI) 53.8 (43.4 – 64.1) 69.7 (59.9 – 79.4) 0.028
Age (yrs), Ме (LQ, UQ) 66 (57, 74) 68 (62, 75) 0.059
BMI (kg/m2), Ме (LQ, UQ) 29.2 (25.8, 32.2) 29.4 (28.7, 37.7) 0.921
Angina pectories (%), М (95% CI) 16.1 (8.5 – 23.7) 11.2 (4.5 – 17.9) 0.339
Prior myocardial infarction (%), М (95% CI) 22.6 (13.9 – 31.2) 10.1 (3.7 – 16.5) 0.024
CAD, other (%), М (95% CI) 55.9 (45.6 – 66.2) 73.0 (63.6 – 82.4) 0.016
Peripheral arteries disease (%), М (95% CI) 7.5 (2.1 – 12.9) 7.9 (2.2 – 13.6) 0.932
SBP (mm Hg), Ме (LQ, UQ) 120 (115, 130) 145 (140, 152) <0.001
DBP (mm Hg), Ме (LQ, UQ) 70 (65, 80) 85 (80, 90) <0.001
Total cholesterol (mg/dl), Ме (LQ, UQ) 186 (171, 217) 213 (190, 229) 0.012
Triglycerides (mg/dl), Ме(LQ, UQ) 72 (61, 88) 96 (65, 175) 0.271
Creatinine (mg/dl), Ме (LQ, UQ) 1.1 (0.9, 1.2) 1.0 (0.9, 1.1) 0.177
Left ventricle hypertrophy on ECG (%), М (95% CI) 7.5 (2.1, 12.9) 22.5 (13.6, 31.3) 0.004
Smoking cessation advice (%), М (95% CI) 2.2 (0.9 – 5.2) 1.1 (0.1 – 3.4) 0.588
Dietary counseling (%), М (95% CI) 53.8 (43.4 – 64.1) 55.1 (44.5 – 65.6) 0.861
Advice on physical activity (%), М (95% CI) 5.4 (0.7 – 10.1) 7.9 (2.2 – 13.6) 0.500
Antihypertensive treatment (n), M±SD 1.63 ± 0.12 1.98 ± 0.11 0.018
No antihypertensive drugs (%), М (95% CI) 12.9 (6.0 – 19.8) 9.0 (2.9 – 15.0) 0.406
One antihypertensive drug (%), М (95% CI) 40.9 (30.7 – 51.0) 21.3 (12.7 – 30.0) 0.005
Two antihypertensive drugs (%), М (95% CI) 21.5 (13.0 – 30.0) 39.3 (29.0 – 49.7) 0.010
Three or more antihypertensive drugs (%), М (95% CI) 24.7 (15.8 – 33.7) 30.3 (20.6 – 40.1) 0.399
ACE-inhibitors (%), М (95% CI) 27.9 (18.7 – 37.2) 39.3 (29.0 – 49.7) 0.105
ARBs (%), М (95% CI) 29.0 (19.6 – 38.4) 30.3 (20.6 – 40.1) 0.848
Beta-blockers (%), М (95% CI) 46.2 (35.9 – 56.6) 57.3 (46.8 – 67.8) 0.136
Dihydrapiridine calcium antagonists (%), М (95% CI) 20.4 (12.1 – 28.8) 21.3 (12.7 – 30.1) 0.879
Non-dihydrapiridine calcium antagonists (%), М (95% CI) 4.3 (0.1 – 8.5) 3.4 (0.1 – 7.2) 0.745
Loop diuretics (%), М (95% CI) 8.6 (2.8 – 14.4) 9.0 (2.9 – 15.0) 0.927
Thiazide diuretics (%), М (95% CI) 3.2 (0.1 – 6.9) 6.7 (1.4 – 12.1) 0.275
Thiazide-like diuretics (%), М (95% CI) 9.7 (3.6 – 15.8) 21.4 (12.7 – 30.0) 0.030
Potassium-sparing diuretics (%), М (95% CI) 14.0 (6.8 – 21.2) 9.0 (2.9 – 15.0) 0.294

ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CAD, coronary arteries disease; CI, confidence interval; ECG, electrocardiogram; LDL, low density lipoprotein; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation.